ChiCTR2100050592Completed
Untitled Trial
Safety, tolerability, pharmacodynamics and efficacy of Yogliptin in patients with type 2 diabetes mellitus
China Japan Friendship HospitalPhase 2Chinese Clinical Trial Registry
Study focus
- Disease/Condition
- Diabetes mellitus
Sponsor & location
- Primary sponsor
- China Japan Friendship Hospital
- Funder
- Chengdu Easton Biopharmaceuticals Co.,Ltd
- Location
- China
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- May 31, 2021
ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100050592
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100050592 through Pure Global AI's free database. This Phase 2 trial is sponsored by China Japan Friendship Hospital and is currently Completed. The study focuses on Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.